Sorafenib has been established as a standard therapy to prolong survival in patients with advanced hepatocellular carcinoma patients when locoregional therapy is not indicated; however the benefit of hepatic arterial infusion chemotherapy (HAIC) as an alternative option remains controversial. Although further research to optimize the use of HAIC and sorafenib is ongoing, we present an overview of the factors influencing the management of long-term survival following sorafenib or HAIC treatment.
We incidentally experienced a case of leiomyoma with latent endometrial carcinoma treated with microwave endometrial ablation (MEA) to control massive menorrhagia by leiomyoma. In the endometrial curettage sample which was obtained during MEA treatment, well differentiated endometrial carcinoma with minimum myometrium invasion was found. The total hysterectomy with both adnexetomy was performed 40 days after MEA. The detail histological examination of excised uterus, both tubes and ovaries had no remaining endometrial carcinoma tissues except for presumable degenerated carcinoma cells within 4 mm depth in myometrium.This report indicates some early case of endometrial carcinoma could be treated with MEA.
The precision of treatment and the diagnosis hepatocellular carcinoma improves by the progress of the supersonic wave model.
Using this model which can display echography to the same screen in real time as reference such as CT or MRI.
Because there was an opportunity to do RFA (radiofrequency ablation) for us using Smart Fusion carried in Toshiba APLIO500, we report it.